Investigators at the Cleveland Clinic Foundation, lead by researcher Yan XSu, PhD of the Departments of Cancer Biology and Obstetrics and Gynecology, reported that preliminary studies showed 48 patients with ovarian cancer had much higher plasma LPA levels than did a comparable group of healthy women.
An enzyme-based assay has recently been developed and that is the first step toward a commercial diagnostic test.
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.